Chinese english Germany Japanese Korea

N-[(3S,4R,5S,9R,10R,13S,14R,17R)-4-hydroxy-10,13-dimethyl-17-[(2R)-1-( 3-propan-2-ylidene-4,5-dihydropyrrol-2-yl)propan-2-yl]-2,3,4,5,6,9,11, 12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide

N-[(3S,4R,5S,9R,10R,13S,14R,17R)-4-hydroxy-10,13-dimethyl-17-[(2R)-1-( 3-propan-2-ylidene-4,5-dihydropyrrol-2-yl)propan-2-yl]-2,3,4,5,6,9,11, 12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide Struktur
159934-15-3
CAS-Nr.
159934-15-3
Englisch Name:
N-[(3S,4R,5S,9R,10R,13S,14R,17R)-4-hydroxy-10,13-dimethyl-17-[(2R)-1-( 3-propan-2-ylidene-4,5-dihydropyrrol-2-yl)propan-2-yl]-2,3,4,5,6,9,11, 12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide
Synonyma:
lokysterolamine B;N-Acetyl-4beta-hydroxy-epi-plakinamine A;Acetamide, N-[(3β,4β,5α,20R)-21-[3,4-dihydro-4-(1-methylethylidene)-2H-pyrrol-5-yl]-4-hydroxy-20-methylpregn-7-en-3-yl]- (9CI);N-[(3S,4R,5S,9R,10R,13S,14R,17R)-4-hydroxy-10,13-dimethyl-17-[(2R)-1-( 3-propan-2-ylidene-4,5-dihydropyrrol-2-yl)propan-2-yl]-2,3,4,5,6,9,11, 12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide
CBNumber:
CB01260182
Summenformel:
C31H48N2O2
Molgewicht:
480.73
MOL-Datei:
159934-15-3.mol
Request For Quotation

N-[(3S,4R,5S,9R,10R,13S,14R,17R)-4-hydroxy-10,13-dimethyl-17-[(2R)-1-( 3-propan-2-ylidene-4,5-dihydropyrrol-2-yl)propan-2-yl]-2,3,4,5,6,9,11, 12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide Eigenschaften

Siedepunkt:
637.4±55.0 °C(Predicted)
Dichte
1.20±0.1 g/cm3(Predicted)
pka
14.35±0.70(Predicted)

Sicherheit

N-[(3S,4R,5S,9R,10R,13S,14R,17R)-4-hydroxy-10,13-dimethyl-17-[(2R)-1-( 3-propan-2-ylidene-4,5-dihydropyrrol-2-yl)propan-2-yl]-2,3,4,5,6,9,11, 12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide Chemische Eigenschaften,Einsatz,Produktion Methoden

N-[(3S,4R,5S,9R,10R,13S,14R,17R)-4-hydroxy-10,13-dimethyl-17-[(2R)-1-( 3-propan-2-ylidene-4,5-dihydropyrrol-2-yl)propan-2-yl]-2,3,4,5,6,9,11, 12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-[(3S,4R,5S,9R,10R,13S,14R,17R)-4-hydroxy-10,13-dimethyl-17-[(2R)-1-( 3-propan-2-ylidene-4,5-dihydropyrrol-2-yl)propan-2-yl]-2,3,4,5,6,9,11, 12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
support@targetmol.com United States 38596 58
  • N-[(3S,4R,5S,9R,10R,13S,14R,17R)-4-hydroxy-10,13-dimethyl-17-[(2R)-1-( 3-propan-2-ylidene-4,5-dihydropyrrol-2-yl)propan-2-yl]-2,3,4,5,6,9,11, 12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide
  • lokysterolamine B
  • Acetamide, N-[(3β,4β,5α,20R)-21-[3,4-dihydro-4-(1-methylethylidene)-2H-pyrrol-5-yl]-4-hydroxy-20-methylpregn-7-en-3-yl]- (9CI)
  • N-Acetyl-4beta-hydroxy-epi-plakinamine A
  • 159934-15-3
  • C31H48N2O2
Copyright 2019 © ChemicalBook. All rights reserved